- Home
- OMIC vs DTIL Comparison
OMIC vs DTIL Comparison
Compare OMIC & DTIL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OMIC
- DTIL
- Stock Information
- Founded
- OMIC 2016
- DTIL 2006
- Country
- OMIC United States
- DTIL United States
- Employees
- OMIC 127
- DTIL N/A
- Industry
- OMIC Medical/Dental Instruments
- DTIL Biotechnology: Pharmaceutical Preparations
- Sector
- OMIC Health Care
- DTIL Health Care
- Exchange
- OMIC Nasdaq
- DTIL Nasdaq
- Market Cap
- OMIC 49.9M
- DTIL 44.1M
- IPO Year
- OMIC 2021
- DTIL 2019
- Fundamental
- Price
- OMIC $19.70
- DTIL $4.96
- Analyst Decision
- OMIC Hold
- DTIL Strong Buy
- Analyst Count
- OMIC 2
- DTIL 3
- Target Price
- OMIC $10.75
- DTIL $37.67
- AVG Volume (30 Days)
- OMIC 21.3K
- DTIL 1.3M
- Earning Date
- OMIC 11-12-2024
- DTIL 11-04-2024
- Dividend Yield
- OMIC N/A
- DTIL N/A
- EPS Growth
- OMIC N/A
- DTIL N/A
- EPS
- OMIC N/A
- DTIL 1.45
- Revenue
- OMIC $2,667,000.00
- DTIL $75,096,000.00
- Revenue This Year
- OMIC $0.82
- DTIL $52.95
- Revenue Next Year
- OMIC $252.64
- DTIL N/A
- P/E Ratio
- OMIC N/A
- DTIL $2.57
- Revenue Growth
- OMIC 2.77
- DTIL 43.62
- 52 Week Low
- OMIC $5.34
- DTIL $3.61
- 52 Week High
- OMIC $23.41
- DTIL $19.43
- Technical
- Relative Strength Index (RSI)
- OMIC 48.55
- DTIL 46.54
- Support Level
- OMIC $19.25
- DTIL $5.10
- Resistance Level
- OMIC $19.90
- DTIL $7.44
- Average True Range (ATR)
- OMIC 0.32
- DTIL 0.66
- MACD
- OMIC 0.02
- DTIL 0.14
- Stochastic Oscillator
- OMIC 54.55
- DTIL 35.25
About OMIC Singular Genomics Systems Inc.
Singular Genomics Systems Inc is a life science technology company that is leveraging novel next generation sequencing and multiomics technologies to build products that empower researchers and clinicians. The product development pipeline comprises two initial integrated solutions, each designed to leverage Sequencing Engine and purpose built to address different applications. The G4 Sequencing Platform is designed to target the NGS market. The PX Integrated Solution is designed to target the single cell, spatial analysis and proteomics markets. Both integrated solutions are used in many different and diverse market segments, including basic biology, oncology, immunology, neurology, genetic diseases, infectious diseases, the human microbiome and many others.
About DTIL Precision BioSciences Inc.
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is also unique in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.